ERG expression in prostate cancer: The prognostic paradox
Authors:
- 29 August 2014
- journal article
- research article
- Published by Wiley in The Prostate
- Vol. 74 (15) , 1481-1487
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Prognostic value of ERG oncoprotein in prostate cancer recurrence and cause‐specific mortalityThe Prostate, 2013
- Immunohistochemistry for ERG Expression as a Surrogate for TMPRSS2-ERG Fusion Detection in Prostatic AdenocarcinomasAmerican Journal of Surgical Pathology, 2011
- Androgen-induced TOP2B-mediated double-strand breaks and prostate cancer gene rearrangementsNature Genetics, 2010
- Clinical Implications of TMPRSS2-ERG Gene Fusion Expression in Patients With Prostate Cancer Treated With Radical ProstatectomyJournal of Urology, 2010
- Reactivation of Androgen Receptor–Regulated TMPRSS2:ERG Gene Expression in Castration-Resistant Prostate CancerCancer Research, 2009
- Recurrent gene fusions in prostate cancerNature Reviews Cancer, 2008
- The Role of SPINK1 in ETS Rearrangement-Negative Prostate CancersCancer Cell, 2008
- Expression of the TMPRSS2:ERG fusion gene predicts cancer recurrence after surgery for localised prostate cancerBritish Journal of Cancer, 2007
- Duplication of the fusion of TMPRSS2 to ERG sequences identifies fatal human prostate cancerOncogene, 2007
- Recurrent Fusion of TMPRSS2 and ETS Transcription Factor Genes in Prostate CancerScience, 2005